Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
Charter Communications is rolling out new pricing and commitments of reliability as it contends with industry shifts in broadband, TV and mobile businesses.
Nestle is launching a line of boxed mac and cheese called Stouffer's Supreme.
The broad market S&P 500 index entered the week less than 1% below a record last reached in July.
These are the stocks posting the largest moves in premarket trading.